Literature DB >> 406157

Serum phenformin concentrations in patients with phenformin-associated lactic acidosis.

L A Conlay, J H Karam, S B Matin, J E Loewenstein.   

Abstract

Phenformin concentrations were measured in serum from seven patients with phenformin-associated lactic acidosis, and initial values ranging from 20 to 625 ng./ml. were obtained. Five of the seven patients had serum concentrations within the usual therapeutic range of up to 241 ng./ml. Serum phenformin concentrations were measured serially, and apparent half-lives of 5, 25, and 30 hours were obtained in three patients with serum creatinine concentrations of 1.7, 7.6, and 6.0 mg./dl., respectively. Although the half-life of phenformin was prolonged in azotemic patients, no correlation between serum creatinine concentration and serum phenformin could be demonstrated; furthermore, the severity of lactic acidosis as measured by arterial pH and lactate concentration did not correlate with the serum creatinine concentration.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 406157     DOI: 10.2337/diab.26.7.628

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  5 in total

1.  An experimental model of phenformin-induced lactic acidosis in rats.

Authors:  R Assan; C Heuclin; J R Girard
Journal:  Diabetologia       Date:  1978-04       Impact factor: 10.122

2.  The effect of short-term administration of antidiabetic biguanide derivatives on the blood lactate levels in healthy subjects.

Authors:  A Czyzyk; B Lao; W Bartosiewicz; Z Szczepanik; K Orlowska
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

Review 3.  The Mechanism of Action of Biguanides: New Answers to a Complex Question.

Authors:  Laura Di Magno; Fiorella Di Pastena; Rosa Bordone; Sonia Coni; Gianluca Canettieri
Journal:  Cancers (Basel)       Date:  2022-06-30       Impact factor: 6.575

Review 4.  Lactic acidosis in biguanide-treated diabetics: a review of 330 cases.

Authors:  D Luft; R M Schmülling; M Eggstein
Journal:  Diabetologia       Date:  1978-02       Impact factor: 10.122

Review 5.  Pharmacokinetic-pharmacodynamic relationships of oral hypoglycaemic agents. An update.

Authors:  P Marchetti; R Navalesi
Journal:  Clin Pharmacokinet       Date:  1989-02       Impact factor: 6.447

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.